Approvals/TGA/IDEFIRIX imlifidase 11 mg powder for concentrate for solution for infusion

Approved

STANDARD

IDEFIRIX imlifidase 11 mg powder for concentrate for solution for infusion

Hansa Biopharma (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 9e8722b10cdfee1f
Product Name: IDEFIRIX imlifidase 11 mg powder for concentrate for solution for infusion
Artg Id: 391413
Artg Name: IDEFIRIX imlifidase 11 mg powder for concentrate for solution for infusion
Sponsor: Hansa Biopharma (Australia) Pty Ltd
Company Detail Path: /organization/hansa-biopharma-australia-pty-ltd
Artg Date: 2023-07-10
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: REP
Product Information: https://medical-cdn.nocode.com/drug_tga/7b3f4133b29c23a250e8198bdf050c92.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

9e8722b10cdfee1f

Type

Standard